Disability and Relapse Risk in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease - PubMed
8 days ago
- #disability
- #MOGAD
- #neurology
- Study investigates the impact of late-onset MOGAD on disability and relapse risk in Korean patients.
- Late-onset MOGAD (≥50 years) was compared with adult-onset MOGAD (18-49 years).
- Late-onset MOGAD showed less frequent brain involvement but higher disability scores at follow-up.
- No significant association was found between late onset and relapse risk.
- Late-onset MOGAD was associated with a higher risk of moderate disability.
- Prospective studies with longer follow-up are needed for better understanding.